Diabetes & Metabolism

Sommaire

• Editorial

  • ·Type 2 diabetes mellitus: integration in view, at last!

    Page :41-42

    P. Lefèbvre

    
  • ·Abnormalities in insulin secretion in type 2 diabetes mellitus

    Page :43-48

    P.-J. Guillausseau, T. Meas, M. Virally, M. Laloi-Michelin, V. Médeau, J.-P. Kevorkian

    Résumé Résumé Plan Plan  
  • ·Pancreatic α-cell dysfunction in diabetes

    Page :49-55

    R. Burcelin, C. Knauf, P.D. Cani

    Résumé Résumé Plan Plan
  • ·β-cell apoptosis in type 2 diabetes: quantitative and functional consequences

    Page :56-64

    R. Lupi, S. Del Prato

    Résumé Résumé Plan Plan  
  • ·Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes

    Page :65-72

    J.-F. Gautier, S.-P. Choukem, J. Girard

    Résumé Résumé Plan Plan  
  • ·GLP-1 receptor signaling: effects on pancreatic β-cell proliferation and survival

    Page :73-77

    J. Buteau

    Résumé Résumé Plan Plan  
  • ·Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies

    Page :78-90

    A. Penfornis, S. Borot, D. Raccah

    Résumé Résumé Plan Plan  
  • ·DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?

    Page :91-95

    S. Halimi

    Résumé Résumé Plan Plan